HIGH PREVALENCE OF ANTI-HEPATITIS A VIRUS IMMUNOGLOBULIN G ANTIBODY AMONG HEALTHCARE FACILITY ATTENDEES IN OSOGBO, NIGERIA
- 1 January 2013
- journal article
- research article
- Published by Taylor & Francis in Journal of Immunoassay and Immunochemistry
- Vol. 34 (1) , 75-82
Abstract
The objectives of this study were to determine the prevalence of anti-hepatitis A virus (HAV) immunoglobulin G (IgG) antibody and associated factors among residents of Osogbo, a town in Nigeria with inadequate environmental sanitation and a shortage of potable water. This is a health facility–based study. Ninety one consenting, asymptomatic attendees of public healthcare facilities in Osogbo, Osun State, Nigeria, were consecutively selected for this study. Plasma samples of the study participants were tested for the presence of anti-HAV IgG using a HAV Ab Competitive Enzyme Immunoassay test kit. Ninety (98.9%) of the participants were seropositive for anti-HAV IgG antibody; group-specific prevalence was also high, but association of participants' variables with the prevalence could not be obtained due to limited sample size and high group-specific prevalence. Since the hepatitis A vaccine is not currently used in Nigeria, the chance is high that the HAV IgG antibody–positive individuals were naturally infected; consequently Osogbo can be described as highly endemic for HAV infectionKeywords
This publication has 12 references indexed in Scilit:
- Analysis of Acute Viral Hepatitis (A and E) in IraqGlobal Journal of Health Science, 2011
- Age-specific seroprevalence of hepatitis A in Antananarivo (Madagascar)BMC Infectious Diseases, 2008
- Hepatitis A Vaccine RecommendationsPediatrics, 2007
- Nationwide Canadian Study of Hepatitis A Antibody Prevalence Among Children Eight to Thirteen Years OldThe Pediatric Infectious Disease Journal, 2005
- The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patternsInternational Journal of Epidemiology, 2005
- Prevalence of hepatitis A antibodies in schoolchildren in Catalonia (Spain) after the introduction of universal hepatitis A immunizationJournal of Medical Virology, 2004
- High Prevalence of Antibodies to Hepatitis A and E Viruses and Viremia of Hepatitis B, C, and D Viruses among Apparently Healthy Populations in MongoliaClinical and Vaccine Immunology, 2004
- Hepatite ARevista da Sociedade Brasileira de Medicina Tropical, 2003
- Viral hepatitis in South African healthcare workers at increased risk of occupational exposure to blood-borne virusesJournal of Hospital Infection, 2002
- Prevalence of antibodies against hepatitis A and E viruses among rural populations of the Chaco region, south‐eastern BoliviaTropical Medicine & International Health, 1999